4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-20-007064
Chief Commercial Officer acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McMullin David Chief Commercial Officer | 2020-03-02 | Grant or award | +250,000 | 257,703 | D | ||
| Derivatives | |||||||
| McMullin David Chief Commercial Officer | 2020-03-02 | Grant or award · Employee Stock Option (Right to Buy) | +247,480 | 247,480 | D | ||
Loading xslF345X03/doc4.xml…